Screening assays for agonists or antagonists of receptor activat or of NF-kB

Details for Australian Patent Application No. 2001293030 (hide)

Owner Immunex Corporation

Inventors Dougall, William C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001293030

PCT Pub. Number WO02/24896

Priority 60/235,157 22.09.00 US

Filing date 20 September 2001

Wipo publication date 2 April 2002

Acceptance publication date 19 July 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

19 July 2007 Application Accepted

  Published as AU-B-2001293030

15 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001293031

2001293029